HAIR

We offer a variety of hair options for women and men ranging from basic cut and style to highlights, gloss, treatments and more.

Learn More

NAILS

From pedicure and manicures to acrylic nails and toes we have just the right option to help you look your best.

Learn More

SPA

Everyone deserves to be pampered. We can  help you relax and rejuvenate w/ a facial, massage or with one of our spa packages.

Learn More

The welfare programs examined in this report are SSI.

Census Bureau data: 57 percent of immigrant households with children receive welfare Census Bureau data display that the share of immigrant-headed households with kids using at least a single welfare program is still very high. This is partly due to the large share of immigrants with low levels of education and their resulting low incomes. The welfare programs examined in this report are SSI , TANF , WIC , free/reduced school lunch, food stamps, Medicaid , general public casing, and rent subsidies. The record entitled: ‘Welfare Use by Immigrant Households with Kids: A glance at Cash, Medicaid, Casing, and Food Applications,’ can be authored by Steven A. Camarota, the Center’s Director of Research, and offered by Among the findings: Predicated on the latest data available, from 2009, 57 % of households headed by an immigrant with children used at least one welfare system, compared to 39 % for native households with kids.Immigrant households with children tend to use meals assistance applications and Medicaid at higher rates than indigenous households with children.The FDA approval of ABRAXANE is interesting for healthcare professionals because it offers an important brand-new treatment choice for all types of non-small cell lung cancer patients, in an area that has noticed few treatment advancements recently. Related StoriesCrucial change in single DNA base predisposes children to intense type of cancerViralytics enters into medical trial collaboration contract with MSDCornell biomedical engineers develop 'super natural killer cells' to destroy tumor cells in lymph nodes The ABRAXANE sNDA approval is based upon the total results of CA-031, a stage III, multi-center, randomized open-label study where patients with advanced non-little cell lung cancer received either ABRAXANE every week plus carboplatin>2) every three weeks plus carboplatin> In the stage III research, ABRAXANE demonstrated an increased overall response rate in comparison with paclitaxel for squamous cell carcinoma and large cell carcinoma .